Teva is proud to be included in the 2025 TIME and Statista list of the World’s Most Sustainable Companies, a recognition that underscores our commitment to building a healthier, more sustainable world.

Selected from over 5,000 companies worldwide, the top 500 were evaluated on more than 20 key performance indicators including carbon emissions reduction, renewable energy use, DE&I, and ESG transparency. Teva’s inclusion reflects our comprehensive approach to sustainability—prioritizing patient access, resilient operations, ethical governance, and climate action.

“This recognition highlights the real and measurable progress Teva is making to embed sustainability into every part of our business,” SVP Head of Sustainability, Amalia Adler-Waxman.

We’re honored to be included and remain committed to delivering long-term value for patients, communities, and the planet.

View the 2024 Healthy Future Report here.

Teva Pharmaceutical

Teva Pharmaceutical

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.

More from Teva Pharmaceutical